Canada’s Medicago says its COVID-19 vaccine shows promising antibody results in trial
Canada’s Medicago says its COVID-19 vaccine shows promising antibody results in trial: Medicago said a Phase 2 clinical trial involving hundreds of participants found the vaccine appears to produce 10 times the antibodies as are seen in people who have had COVID-19. Link: https://globalnews.ca/feed/ May 18, 2021 Twitter: @hoffeldtcom